---
category: news
title: "Resverlogix Receives Ethics Approval for Canadian Sites in Apabetalone COVID-19 Clinical Trial"
excerpt: "Resverlogix Corp. (\"Resverlogix\" or the \"Company\") , today announces the approval of its COVID-19 clinical trial of apabetalone by the Health Research Ethics Board (HREB) ? Biomedical Panel at the University of Alberta."
publishedDateTime: 2021-10-12T21:40:00Z
originalUrl: "https://www.lelezard.com/en/news-20042913.html"
webUrl: "https://www.lelezard.com/en/news-20042913.html"
type: article
quality: 27
heat: 27
published: false

provider:
  name: Le LÃ©zard
  domain: lelezard.com

topics:
  - AI Ethics
  - AI

images:
  - url: "https://www.lelezard.com/img/pr_sections/health.jpg"
    width: 640
    height: 480
    isCached: true

secured: "bje7Ri3d1diPVrMtoorQN33fG4WG9xfppqYy2Sr2EOuwsCgWT65tPgGlBCoBuaEf6EDSad8a2/Gn7fBMZtBMxmku9Z05/Rw/y7dqH5cSL07mSONlLf9icKxx31mbxhZwXgc5KCRNlXloknqzFeK/wpQsW+itpiMwmzqk7TFGN5NLK+rfpv0OVlDQrCDfl3lD0uW+WmF9zGvMxQsmgy2HhX6NQLIiAX5Hq+zmg1ZgQH+J4ocXX/+Yv1eHjVXeB55GIpsYMZBG9vFA5+BwgW5apMg8rI8RzGzS9Ri9Wce/tByULc3QLz4ivQFQmLesXdUFGZLbgDnlWhW6mIs76c9oTH0LlspDGkasskcZO1DEDvA=;grwuGATg95Ril4N9I63kUw=="
---

